Drug interaction classified as: synergy
Source: DDInter
Serotonin-Norepinephrine Reuptake Inhibitor · Antidepressant, Anxiolytic
Milnacipran inhibits both the neuronal serotonin/5HT transporter (SERT) and the neuronal NE transporter (NET), enhancing both serotonergic and noradrenergic neurotransmission. Initial inhibition of SERT activates 5HT1A and 5HT1D autoreceptors, decreasing transmission until desensitization. Repeated treatment reduces expression of SERT or NET, leading to increased neurotransmitter clearance.
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy.
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
Drug interaction classified as: synergy
Source: DDInter
.
Source: DDInter
Clinical effect not specified
Source: DDInter
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team